Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 7, 2010, Pages 3368-3376

  Chun, Rene F ^a   Lauridsen, Anna L ^c   Suon, Lizabeth ^a   Zella, Lee A ^d   Pike, J Wesley ^d   Modlin, Robert L ^a,b   Martineau, Adrian R ^e,g   Wilkinson, Robert J ^f,g,h   Adams, John ^a   Hewison, Martin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RANDERS REGIONAL HOSPITAL   (Denmark)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^h UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; CALCITRIOL; CATHELICIDIN; MEGALIN; MESSENGER RNA; OXYGENASE; VITAMIN D BINDING PROTEIN; 1,25-DIHYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; ANTIMICROBIAL CATIONIC PEPTIDE; CAP18 LIPOPOLYSACCHARIDE BINDING PROTEIN; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN; DRUG DERIVATIVE; VITAMIN D;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CULTURE MEDIUM; FLOW CYTOMETRY; GENE EXPRESSION; GENOTYPE; HUMAN; HUMAN CELL; KNOCKOUT GENE; METABOLITE; MICROSCOPY; MOLECULAR MECHANICS; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANALYSIS OF VARIANCE; ANIMAL; CELL CULTURE; CYTOLOGY; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANALYSIS OF VARIANCE; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CELLS, CULTURED; FLOW CYTOMETRY; GENOTYPE; HUMANS; MICE; MONOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VITAMIN D; VITAMIN D-BINDING PROTEIN;

EID: 77954907455     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0195     Document Type: Article

References (44)

1. Adams JS, Hewison M 2008 Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 4:80-90 (Pubitemid 351156900)
2. Adams JS, Ren S, Liu PT, Chun RF, Lagishetty V, Gombart AF, Borregaard N, Modlin RL, Hewison M 2009 Vitamin D-directed rheostatic regulation of monocyte antibacterial responses. J Immunol 182:4289-4295
3. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zügel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL 2006 Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311:1770-1773
4. Krutzik SR, Hewison M, Liu PT, Robles JA, Stenger S, Adams JS, Modlin RL 2008 IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J Immunol 181:7115-7120
5. Martineau AR, Wilkinson KA, Newton SM, Floto RA, Norman AW, Skolimowska K, Davidson RN, Sørensen OE, Kampmann B, Griffiths CJ, Wilkinson RJ 2007 IFN-γ- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J Immunol 178:7190-7198 (Pubitemid 46847445)
6. Gombart AF, Borregaard N, Koeffler HP 2005 Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J 19:1067-1077 (Pubitemid 40946432)
7. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, Tavera-Mendoza L, Lin R, Hanrahan JW, Mader S, White JH, Hanrahan JH 2004 Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173:2909-2912 (Pubitemid 39141992)
8. Gombart AF, Saito T, Koeffler HP 2009 Exaptation of an ancient Alu short interspersed element provides a highly conserved vitamin D-mediated innate immune response in humans and primates. BMC Genomics 10:321
9. Holick MF 2009 Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 19:73-78
10. Holick MF, Chen TC 2008 Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87:1080S-1086S
11. Holick MF 2007 Vitamin D deficiency. N Engl J Med 357:266-281
12. White P, Cooke N 2000 The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab 11:320-327
13. Laing JCN 2005 Vitamin D-binding protein. In: Feldman D, Pike JW, Glorieux FH, eds. Vitamin D. Amersterdam: Elsevier; 117-152
14. Nykjaer A, Dragun D, Walther D, Vorum H, Jacobsen C, Herz J, Melsen F, Christensen EI, Willnow TE 1999 An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96:507-515 (Pubitemid 29106838)
15. Rowling MJ, Kemmis CM, Taffany DA, Welsh J 2006 Megalin-mediated endocytosis of vitamin D binding protein correlates with 25- hydroxycholecalciferol actions in human mammary cells. J Nutr 136:2754-2759 (Pubitemid 44771769)
16. Nykjaer A, Fyfe JC, Kozyraki R, Leheste JR, Jacobsen C, Nielsen MS, Verroust PJ, Aminoff M, de la Chapelle A, Moestrup SK, Ray R, Gliemann J, Willnow TE, Christensen EI 2001 Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D3. Proc Natl Acad Sci USA 98:13895-13900 (Pubitemid 33115995)
17. Le Panse S, Galceran M, Pontillon F, Lelongt B, van de Putte M, Ronco PM, Verroust PJ 1995 Immunofunctional properties of a yolk sac epithelial cell line expressing two proteins gp280 and gp330 of the intermicrovillar area of proximal tubule cells: inhibition of endocytosis by the specific antibodies. Eur J Cell Biol 67:120-129
18. Martineau AR, Leandro AC, Anderson ST, Newton SM, Wilkinson KA, Nicol MP, Pienaar SM, Skolimowska KH, Rocha MA, Rolla VC, Levin M, Davidson RN, Bremner SA, Griffiths CJ, Eley BS, Bonecini-Almeida MG, Wilkinson RJ 24 September 2009 Association between Gc genotype and susceptibility to TB is dependent on vitamin D status. Eur Respir J 0:09031936.00087009v1
19. Lauridsen AL, Vestergaard P, Nexo E 2001 Mean serum concentration of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in women. Clin Chem 47:753-756 (Pubitemid 32275824)
20. Safadi FF, Thornton P, Magiera H, Hollis BW, Gentile M, Haddad JG, Liebhaber SA, Cooke NE 1999 Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest 103:239-251 (Pubitemid 29053142)
21. Zella LA, Shevde NK, Hollis BW, Cooke NE, Pike JW 2008 Vitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo. Endocrinology 149:3656-3667
22. Arnaud J, Constans J 1993 Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum Genet 92:183-188 (Pubitemid 23272286)
23. Bikle DD, Gee E, Halloran B, Kowalski MA, Ryzen E, Haddad JG 1986 Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab 63:954-959 (Pubitemid 16004301)
24. Bikle DD, Gee E, Halloran B, Haddad JG 1984 Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J Clin Invest 74:1966-1971 (Pubitemid 15197337)
25. Bouillon R, Van Assche FA, Van Baelen H, Heyns W, De Moor P 1981 Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration. J Clin Invest 67:589-596 (Pubitemid 11142347)
26. Mendel CM 1989 The free hormone hypothesis: a physiologically based mathematical model. Endocr Rev 10:232-274
27. Hammond GL 2002 Access of reproductive steroids to target tissues. Obstet Gynecol Clin North Am 29:411-423
28. Chlon TM, Taffany DA, Welsh J, Rowling MJ 2008 Retinoids modulate expression of the endocytic partners megalin, cubilin, and disabled-2 and uptake of vitamin D-binding protein in human mammary cells. J Nutr 138:1323-1328 (Pubitemid 351930997)
29. Sanger JM, Dabiri G, Mittal B, Kowalski MA, Haddad JG, Sanger JW 1990 Disruption of microfilament organization in living nonmuscle cells by microinjection of plasma vitamin D-binding protein or DNase I. Proc Natl Acad Sci USA 87:5474-5478 (Pubitemid 20260203)
30. Sanger JM, Mittal B, Southwick FS, Sanger JW 1995 Listeria monocytogenes intracellular migration: inhibition by profilin, vitamin D-binding protein and DNase I. Cell Motil Cytoskeleton 30:38-49
31. Yamamoto N, Homma S, Millman I 1991 Identification of the serum factor required for in vitro activation of macrophages. Role of vitamin D3-binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages. J Immunol 147:273-280
32. Yamamoto N, Naraparaju VR 1996 Role of vitamin D3-binding protein in activation of mouse macrophages. J Immunol 157:1744-1749 (Pubitemid 126449119)
33. Kanda S, Mochizuki Y, Miyata Y, Kanetake H, Yamamoto N 2002 Effects of vitamin D3-binding protein-derived macrophage activating factor (GcMAF) on angiogenesis. J Natl Cancer Inst 94:1311-1319
34. Swamy N, Ghosh S, Schneider GB, Ray R 2001 Baculovirus-expressed vitamin D-binding protein-macrophage activating factor (DBP-maf) activates osteoclasts and binding of 25-hydroxyvitamin D3 does not influence this activity. J Cell Biochem 81:535-546 (Pubitemid 32405771)
35. Hirschfled J, Jonsson B, M R 1959 Immune electrophoretic demonstration of qualitative differences in human sera and their relation to the haptoglobins. Acta Pathol Microbiol 47:160-168
36. Lauridsen AL, Vestergaard P, Hermann AP, Brot C, Heickendorff L, Mosekilde L, Nexo E 2005 Plasma concentrations of 25-hydroxyvitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int 77:15-22 (Pubitemid 41504168)
37. Jablonski NG, Chaplin G 2000 The evolution of human skin coloration. J Hum Evol 39:57-106
38. Kappelman J, Alçiçek MC, Kazanci N, Schultz M, Ozkul M, Sen S 2008 First Homo erectus from Turkey and implications for migrations into temperate Eurasia. Am J Phys Anthropol 135:110-116 (Pubitemid 350308743)
39. Shoenfeld N, Amital H, Shoenfeld Y 2009 The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease. Nat Clin Pract Rheumatol 5:99-105
40. Grant WB, Mohr SB 2009 Ecological studies of ultraviolet B, vitamin D and cancer since 2000. Ann Epidemiol 19:446-454
41. Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM 2007 Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab 92:3517-3522 (Pubitemid 47435329)
42. Ishii T, Keicho N, Teramoto S, Azuma A, Kudoh S, Fukuchi Y, Ouchi Y, Matsuse T 2001 Association of Gc-globulin variation with susceptibility to COPD and diffuse panbronchiolitis. Eur Respir J 18:753-757 (Pubitemid 33076915)
43. Pollard DR, Gill P, Day A 1988 The group-specific protein marker: a possible indicator of syphilis, not human immunodeficiency virus infection. CMAJ 138:1013-1015
44. Janssens W, Bouillon R, Claes B, Carremans C, Lehouck A, Buysschaert I, Coolen J, Mathieu C, Decramer M, Lambrechts D 2009 Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 65:215-220